Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
Whats New at the pCPA
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Dayvigo (lemborexant)
pCPA File Number:
22188
Negotiation Status:
Active Negotiation
Indication(s):
Insomnia
Sponsor/Manufacturer:
Eisai Limited
CADTH Project Number:
SR0716
pCPA Engagement Letter Issued:
2023-05-09
Negotiation Process Concluded:
Not Applicable